Bond AbbVie Inc. 4.75% ( US00287YDB20 ) in USD
| Issuer | AbbVie Inc. |
| Market price | |
| Country | United States
|
| ISIN code |
US00287YDB20 ( in USD )
|
| Interest rate | 4.75% per year ( payment 2 times a year) |
| Maturity | 14/03/2045 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 827 091 000 USD |
| Cusip | 00287YDB2 |
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) |
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) |
| Next Coupon | 15/03/2026 ( In 130 days ) |
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie Inc. ( United States ) , in USD, with the ISIN code US00287YDB20, pays a coupon of 4.75% per year. The coupons are paid 2 times per year and the Bond maturity is 14/03/2045 The Bond issued by AbbVie Inc. ( United States ) , in USD, with the ISIN code US00287YDB20, was rated Baa2 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie Inc. ( United States ) , in USD, with the ISIN code US00287YDB20, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
Français
Italiano
United States